Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001837607-25-000079
Filing Date
2025-11-13
Accepted
2025-11-13 16:05:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A aeon-20231109xdefa14a.htm DEFA14A 47027
2 GRAPHIC aeon-20231109xdefa14a002.jpg GRAPHIC 3786
  Complete submission text file 0001837607-25-000079.txt   53528
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40021 | Film No.: 251478315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)